Current progress in cancer immunotherapy based on natural killer cells - Bagheri - 2021 - Cell Biology International - Wiley Online Library
Cells | Free Full-Text | Human Fibroblast Growth Factor-Treated Adipose-Derived Stem Cells Facilitate Wound Healing and Revascularization in Rats with Streptozotocin-Induced Diabetes Mellitus
Onco | Free Full-Text | Role of NK Cells in Cancer and Immunotherapy
Cells | Free Full-Text | Human Fibroblast Growth Factor-Treated Adipose-Derived Stem Cells Facilitate Wound Healing and Revascularization in Rats with Streptozotocin-Induced Diabetes Mellitus
Cells | Free Full-Text | Human Fibroblast Growth Factor-Treated Adipose-Derived Stem Cells Facilitate Wound Healing and Revascularization in Rats with Streptozotocin-Induced Diabetes Mellitus
Akademon
ISCT 2021 Annual Report – Sustaining Connections in CGT
NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy | SpringerLink
Cancers | Free Full-Text | Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and
Endothelial Progenitor Cells Are Rapidly Recruited to Myocardium and Mediate Protective Effect of Ischemic Preconditioning via “Imported” Nitric Oxide Synthase Activity | Circulation
Akademon
Cells | Free Full-Text | Human Fibroblast Growth Factor-Treated Adipose-Derived Stem Cells Facilitate Wound Healing and Revascularization in Rats with Streptozotocin-Induced Diabetes Mellitus
Cells | Free Full-Text | Human Fibroblast Growth Factor-Treated Adipose-Derived Stem Cells Facilitate Wound Healing and Revascularization in Rats with Streptozotocin-Induced Diabetes Mellitus
ISCT 2021 Annual Report – Sustaining Connections in CGT
Massive ex Vivo Expansion of Human Natural Regulatory T Cells (Tregs) with Minimal Loss of in Vivo Functional Activity | Science Translational Medicine
Review
NK cells to cure cancer - ScienceDirect
Claudia Raggi – ISCT 2021 Annual Report
NKG2D Ligands in Cancer
Leveraging biomaterials for enhancing T cell immunotherapy - ScienceDirect
Slabá imunita? Začni od základu, prečisti svoje bunky - DDR Prime, DNA damage repair - zdravievkvapke.sk
Cancers | Free Full-Text | Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics
Frontiers | Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3+CD5dimCD21− Cytotoxic Large Granular Lymphocytes
